Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects
This study has been terminated.
( Futility boundary at interim analysis not met )
Study NCT00498914 Information provided by Astellas Pharma Inc
First Received: July 10, 2007 Last Updated: May 8, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma, Large-Cell, Diffuse
Lymphoma, B-Cell Refractory
Additional conditions recognized in this trial
Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
YM155
Sponsors listed in this trial
Astellas Pharma Inc
Back to top of Main Content